Skip to main content

Clinical trial ROSALINE

Neoadjuvant study of targeting ROS1 in combination with endocrine therapy in invAsive Lobular carcINoma of the breast

Cancers
Organ Breast
Trial status Trial closed for recruitment
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Oui
Sponsor Institut Jules Bordet
EudraCT Identifier 2019-004942-14
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT04551495
Last update